Nishimura et al., 2015 - Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity. Frontiers in pharmacology   6:199 Full text @ Front Pharmacol
Human Disease / Model Data (1 Record)
Human Disease Fish Environment Evidence Code
obesity mitfab692/b692; ednrbab140/b140 increased food availability
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.